WATERS CORP /DE/ (WAT)
Laboratory Analytical Instruments · Healthcare · $35.4B
Intrinsic Value (Consensus)
$166.03
Current Price
$360.54
Margin of Safety
-53.9%
53.9% Above Intrinsic Value
Value: $166
Price: $361
Valuation Model Estimates
Current Price: $360.54
DCF (Discounted Cash Flow)
$264.97
Graham Number
$79.48
Earnings Power Value
$104.47
Relative Value (P/E)
$215.20
Dividend Discount Model
Not applicable
—
Consensus Value
$166.03
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
76
Profitability
25/25
Strength
22/25
Valuation
7/25
Growth
22/25
Financial Health Signals
Strong profitability — ROE of 25% (above 20% is excellent)
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $10.76
- EPS (Forward)
- $12.91
- Book Value
- $26.09
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 25.1%
- Debt/Equity
- 55%
- Revenue Growth
- 295.7%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance